Antithrombotic Drug Therapy in Cardiovascular Disease

Substantial morbidity and mortality remains associated with thrombotic events has stimulated the rapid expansion of the available armamentarium to combat pathologic thrombosis. Pathologic thrombosis plays an essential role in the pathogenesis of acute coronary syndromes (ACS), ischemic complications...

Full description

Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Askari, Arman T. (Editor), Lincoff, A. Michael. (Editor)
Format: Electronic
Language:English
Published: Totowa, NJ : Humana Press : Imprint: Humana Press, 2010.
Series:Contemporary Cardiology
Subjects:
Online Access:https://ezaccess.library.uitm.edu.my/login?url=http://dx.doi.org/10.1007/978-1-60327-235-3
LEADER 04224nam a22005175i 4500
001 9306
003 DE-He213
005 20130725195618.0
007 cr nn 008mamaa
008 100715s2010 xxu| s |||| 0|eng d
020 # # |a 9781603272353  |9 978-1-60327-235-3 
024 7 # |a 10.1007/978-1-60327-235-3  |2 doi 
050 # 4 |a RC681-688.2 
072 # 7 |a MJD  |2 bicssc 
072 # 7 |a MED010000  |2 bisacsh 
082 0 4 |a 616.12  |2 23 
100 1 # |a Askari, Arman T.  |e editor. 
245 1 0 |a Antithrombotic Drug Therapy in Cardiovascular Disease  |c edited by Arman T. Askari, A. Michael Lincoff.  |h [electronic resource] / 
264 # 1 |a Totowa, NJ :  |b Humana Press :  |b Imprint: Humana Press,  |c 2010. 
300 # # |a VIII, 880p. 69 illus., 11 illus. in color.  |b online resource. 
336 # # |a text  |b txt  |2 rdacontent 
337 # # |a computer  |b c  |2 rdamedia 
338 # # |a online resource  |b cr  |2 rdacarrier 
347 # # |a text file  |b PDF  |2 rda 
490 1 # |a Contemporary Cardiology 
505 0 # |a The Platelet in Arterial and Venous Thrombosis -- The Coagulation Cascade in Arterial and Venous Thrombosis -- The Link Between Thrombosis and Inflammation -- Genetics of Thrombosis -- Aspirin for Primary and Secondary Prevention -- Thienopyridines in Stable CAD Patients -- Anti-platelet Therapies: Aspirin, Thienopyridines, and Glycoprotein IIb/IIIa Inhibitors -- Unfractionated Heparin and Enoxaparin -- The Direct Thrombin Ihibitors -- Synthetic Factor Xa Inhibition, Fondaparinux -- Antiplatelet Therapies: Aspirin,Clopidogrel and thienopyridines and Glycoprotien IIb/IIIa Inhibitors -- Antithrombin Therapies: Unfractionated Heparin, Enoxaparin, Direct Thrombin Inhibitors, Fondaparinux -- Fibrinolysis and Facilitated PCI -- Antithrombotic Therapy in Percutaneous Coronary Intervention -- Antithrombotic Therapy in Carotid and Peripheral Intervention -- Monitoring of Antithrombotic Therapies -- Antithrombotic Therapy for DVT/PE -- Fibrinolysis for PE -- Duration of Anticoagulation Following VTE.-Antithrombotic Therapy for Atrial Fibrillation -- Antithrombotic Therapy for Valvular Heart Disease -- Antithrombotic Therapy for Cardiomyopathy -- Heparin-Induced Thrombocytopenia -- "Resistance" to Antiplatelet Therapies. 
520 # # |a Substantial morbidity and mortality remains associated with thrombotic events has stimulated the rapid expansion of the available armamentarium to combat pathologic thrombosis. Pathologic thrombosis plays an essential role in the pathogenesis of acute coronary syndromes (ACS), ischemic complications of percutaneous coronary intervention (PCI), venous thromboembolic disease, and embolic complications of arrhythmias and various cardiomyopathies. Written by experts in the field, Antithrombotic Drug Therapy in Cardiovascular Disease carefully examines individual and various combinations of the available antithrombotic regimens including fibrinolytic agents, antiplatelet therapies (aspirin, thieneopyridines, glycoprotein IIb/IIIa inhibitors), and anticogulant therapies (unfractionated heparin, low-molecular-weight heparins, direct thrombin inhibitors, and synthetic factor X inhibitors), non-ST-segment elevation (NSTE) ACS and ST-segment elevation myocardial infarction (STEMI). A detailed overview, Antithrombotic Drug Therapy in Cardiovascular Disease presents the evidence demonstrating the efficacy of available antithrombotic therapies in specific disease states such as atrial fibrillation, cardiomyopathy, valvular heart disease, and heparin-induced thrombocytopenia (HIT). 
650 # 0 |a Medicine. 
650 # 0 |a Interventional radiology. 
650 # 0 |a Internal medicine. 
650 # 0 |a Cardiology. 
650 # 0 |a Vascular Surgery. 
650 1 4 |a Medicine & Public Health. 
650 2 4 |a Cardiology. 
650 2 4 |a Internal Medicine. 
650 2 4 |a Interventional Radiology. 
650 2 4 |a Vascular Surgery. 
700 1 # |a Lincoff, A. Michael.  |e editor. 
710 2 # |a SpringerLink (Online service) 
773 0 # |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9781603272346 
830 # 0 |a Contemporary Cardiology 
856 4 0 |u https://ezaccess.library.uitm.edu.my/login?url=http://dx.doi.org/10.1007/978-1-60327-235-3 
912 # # |a ZDB-2-SME 
950 # # |a Medicine (Springer-11650)